Status:
COMPLETED
Cancer in Nursing Home Residents
Lead Sponsor:
European Organisation for Research and Treatment of Cancer - EORTC
Collaborating Sponsors:
Armonea
Conditions:
Armonea Nursing Homes Residents
Eligibility:
All Genders
65+ years
Brief Summary
Cancer is a disease of the elderly. Cancer incidence is 11-fold higher in persons over the age of 65, than in younger ones. Approximately 60% of all cancers and 70% of cancer mortality occurs in peopl...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- All individuals:
- Age ≥ 65 years
- Residents in a nursing home in the Armonea network in Belgium.
- Absence of any psychological, familial, or sociological condition potentially hampering compliance with the study protocol; those conditions should be discussed with the patient/proxy before registration in the study.
- Written informed consent must be given according to ICH/GCP, and national/local regulations.
- The treating general practitioner (GP) is willing to provide medical information required by the study.
- Cancer patient cohort:
- Patients must have a new cancer event defined as one of:
- A strong clinical suspicion (based on physician's judgement) of a new cancer where a diagnostic or therapeutic decision needs to be taken.
- A strong clinical suspicion (based on physician's judgement) of progression of a previously known cancer where a diagnostic or therapeutic decision needs to be taken.
- Diagnosis of a new cancer where a diagnostic or therapeutic decision needs to be taken.
- Diagnosis of progression of a previously known cancer where a diagnostic or therapeutic decision needs to be taken.
- All invasive cancer types and all histologies are eligible. All lines of treatment are eligible. Patients who are diagnosed with cancer during routine medical examinations for some other medical condition
- Control cohort:
- • Absence of known active invasive cancer, or strong clinical suspicion of cancer (based on physician's judgement) at baseline.
- Exclusion criteria:
- Patients who were not suspected to have cancer (progression) in the nursing home, but are hospitalized for other (medical) reasons, are then diagnosed with cancer during hospitalization.
Exclusion
Key Trial Info
Start Date :
October 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2017
Estimated Enrollment :
125 Patients enrolled
Trial Details
Trial ID
NCT01910376
Start Date
October 1 2014
End Date
December 1 2017
Last Update
March 13 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Armonea nursing homes network
Mechelen, Belgium